Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04596774
Other study ID # 2020/965
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2018
Est. completion date August 30, 2020

Study information

Verified date October 2020
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Aim: Orthognathic surgeries are generally associated with blood loss, swelling, postoperative nausea vomiting (PONV), and pain. The aim of this study is to improve postoperative outcome in patients undergoing orthognatic surgeries by the use of Enhanced Recovery After Surgery (ERAS) protocols. Material methods: After Ethics Committee approval (2020/965), the data of 90 patients who underwent elective orthognathic surgery, were investigated. Following standard monitorization and general anesthesia; Group 1 patients were applied traditional approach and received intraoperative 10 mL/kg/h IV izolen infusion. Group 2 received ERAS approach. Patients in Group 2 did not preoperatively smoke for 48 hours, drank clear liquids until the last 2 hours, and received 6 mL/kg/h IV izolen intraoperatively. In these; gastric aspiration was also applied before extubation, PONV prophylaxis and patient controlled analgesia was added to the routine plans for the first postoperative 48 hours. The primary endpoint was length of hospital stay. The secondary endpoints were intraoperative follow-up data, length of postanesthesia care unit (PACU) stay, numeric rating scale (NRS) pain scores, opioid consumption and PONV incidences through the postoperative first 48 hours, and satisfaction scores.


Description:

Aim: Orthognathic surgeries are extensive surgeries including both soft and hard tissues of the facial region of the skull associated with blood loss, inflammatory reactions, massive swelling, postoperative nausea vomiting (PONV), and severe pain. Therefore; in most of the patients who are with dentofacial deformity and undergo orthognathic surgery, postoperative recovery generally requires a long troublesome period. The aim of this study is to improve postoperative outcome by the use of Enhanced Recovery After Surgery (ERAS) protocols. Material methods: After Ethics Committee approval (2020/965), the data of 90 patients who underwent elective orthognathic surgery, were investigated. Following standard monitorization and general anesthesia; Group 1 patients were applied traditional approach and received intraoperative 10 mL/kg/h IV izolen infusion. Rescue analgesics and PONV prophylaxis were applied when required through the postoperative first 48 hours. Group 2 received ERAS approach. Patients in Group 2 did not preoperatively smoke for 48 hours, drank clear liquids until the last 2 hours, and received 6 mL/kg/h IV izolen infusion intraoperatively. In these; gastric aspiration was also applied before extubation, PONV prophylaxis was supported routinely, and patient controlled analgesia was added to the routine analgesia plan for the first postoperative 48 hours. The primary endpoint was length of hospital stay. The secondary endpoints were intraoperative follow-up data, numeric rating scale (NRS) pain scores, opioid consumption, PONV incidences, length of postanesthesia care unit (PACU) stay, satisfaction scores of two groups through the postoperative first 48 hours.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date August 30, 2020
Est. primary completion date August 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Patients undergoing orthognathic surgery (bimaxillary, mandibular/maxillary) - Patients aged between 18 and 40 years of age - American Society of Anesthesiologists (ASA) physical status of 1-2 - Capable of understanding the instructions for using the NRS pain scores - Capable of replying the study-based questions - Absence of mental/psychiatric disorders - Absence of chronic analgesic/opioid use - Absence of alcohol/illicit drug use Exclusion Criteria - Patients who are younger than 18 years of age - Patients who are older than 45 years of age - American Society of Anesthesiologists (ASA) physical status of 3-4 - Not capable of consenting - Not capable of understanding the instructions for using the NRS pain - scores - Not capable of replying the study-based questions - Presence of mental/psychiatric disorders - Presence of chronic analgesic/opioid use - Presence of alcohol/illicit drug use

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Traditional Approach
Patients received intraoperative 10 mL/kg/h IV izolen infusion. Opioids and PONV prophylaxis were applied when required.
Enhanced Recovery After Surgery (ERAS) Approach
Patients did not preoperatively smoke for 48 hours, drank clear liquids until the last 2 hours and received 6 mL/kg/h IV izolen infusion intraoperatively. In these; gastric aspiration was applied before extubation, PONV prophylaxis was supported routinely, and patient controlled analgesia was added to the routine analgesia plan for the first postoperative 48 hours.

Locations

Country Name City State
Turkey Istanbul University, Istanbul Faculty of Medicine Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Agbaje J, Luyten J, Politis C. Pain Complaints in Patients Undergoing Orthognathic Surgery. Pain Res Manag. 2018 Jul 15;2018:4235025. doi: 10.1155/2018/4235025. eCollection 2018. — View Citation

Dobbeleir M, De Coster J, Coucke W, Politis C. Postoperative nausea and vomiting after oral and maxillofacial surgery: a prospective study. Int J Oral Maxillofac Surg. 2018 Jun;47(6):721-725. doi: 10.1016/j.ijom.2017.11.018. Epub 2018 Jan 1. — View Citation

Lin S, McKenna SJ, Yao CF, Chen YR, Chen C. Effects of Hypotensive Anesthesia on Reducing Intraoperative Blood Loss, Duration of Operation, and Quality of Surgical Field During Orthognathic Surgery: A Systematic Review and Meta-Analysis of Randomized Cont — View Citation

Mobini A, Mehra P, Chigurupati R. Postoperative Pain and Opioid Analgesic Requirements After Orthognathic Surgery. J Oral Maxillofac Surg. 2018 Nov;76(11):2285-2295. doi: 10.1016/j.joms.2018.05.014. Epub 2018 May 19. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Length of hospital stay Post Anaesthetic Discharge Scoring System (PADSS) (=9/10) 0-48 hours
Secondary Mean arterial pressure (MAP) Intraoperative follow-up 0-5 hours
Secondary Heart rate Intraoperative follow-up 0-5 hours
Secondary Intraoperative fentanyl requirement Intraoperative follow-up 0-5 hours
Secondary The amount of blood loss Intraoperative follow-up (aspirator and gases) 0-5 hours
Secondary The difference of preoperative-postoperative haemoglobin values Preop Hb-Postop Hb 0-12 hours
Secondary Length of stay in postoanesthesia care unit (PACU) Modified Aldrete Scoring system (=9/10) 0-1 hours
Secondary Pain (Numeric rating scale (NRS)) scores Postoperative Numeric rating scale (NRS) pain scores (0: no pain, 10: worst pain imaginable) 0-48 hours
Secondary Opioid (meperidine) consumption Amount of opioid administered to the patient through the postoperative first 48 hours (Group 1: NRS=4, Group 2: Patient controlled analgesia system) 0-48 hours
Secondary Incidence of postoperative nausea and vomiting (PONV) Number of feeling nausea or vomiting (on postoperative days 1 and 2) 0-48 hours
Secondary Postoperative first oral intake First oral liquid (water) intake time (postoperatively as soon as possible) 0-24 hours
Secondary Postoperative first passage of flatus or stool First passage of flatus or stool (postoperatively as soon as possible) 0-24 hours
Secondary Postoperative first mobilization First mobilization time (standing up-walking for any reason) (postoperatively as soon as possible) 0-24 hours
Secondary Patient satisfaction Satisfaction score: 0: very unsatisfied, 3: very satisfied 0-48 hours
Secondary Surgeon satisfaction Satisfaction score: 0: very unsatisfied, 3: very satisfied 0-48 hours
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2